Stephan Kirchner

2.1k total citations · 1 hit paper
18 papers, 972 citations indexed

About

Stephan Kirchner is a scholar working on Molecular Biology, Cancer Research and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Stephan Kirchner has authored 18 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Stephan Kirchner's work include Carcinogens and Genotoxicity Assessment (7 papers), DNA Repair Mechanisms (4 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). Stephan Kirchner is often cited by papers focused on Carcinogens and Genotoxicity Assessment (7 papers), DNA Repair Mechanisms (4 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). Stephan Kirchner collaborates with scholars based in Switzerland, Germany and United States. Stephan Kirchner's co-authors include Silvio Albertini, Micheline Kirsch‐Volders, Takeshi Morita, Michael Fenech, Elisabeth Lorge, Toshio Sofuni, David A. Eastmond, Akihiro Wakata, Jordi Surrallés and Marilyn J. Aardema and has published in prestigious journals such as Trends in Genetics, PLoS Computational Biology and Drug Discovery Today.

In The Last Decade

Stephan Kirchner

18 papers receiving 922 citations

Hit Papers

Report from the in vitro micronucleus assay working group 2003 2026 2010 2018 2003 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephan Kirchner Switzerland 11 449 417 228 182 153 18 972
Mike O’Donovan United Kingdom 14 476 1.1× 352 0.8× 271 1.2× 181 1.0× 55 0.4× 24 946
G. Jean Horbach Netherlands 20 247 0.6× 380 0.9× 182 0.8× 143 0.8× 61 0.4× 45 1.0k
Alan L. Mendrala United States 13 510 1.1× 313 0.8× 367 1.6× 168 0.9× 48 0.3× 17 998
Catherine S. Sprankle United States 15 187 0.4× 241 0.6× 178 0.8× 62 0.3× 133 0.9× 20 693
Sandro Grilli Italy 20 601 1.3× 399 1.0× 326 1.4× 202 1.1× 29 0.2× 124 1.2k
Barbara Heinrich-Hirsch Germany 14 310 0.7× 190 0.5× 402 1.8× 100 0.5× 63 0.4× 25 825
Linda Pluta United States 20 426 0.9× 545 1.3× 258 1.1× 85 0.5× 34 0.2× 40 1.0k
Maurizio Taningher Italy 17 539 1.2× 473 1.1× 242 1.1× 163 0.9× 60 0.4× 59 1.0k
Maik Schuler United States 20 647 1.4× 490 1.2× 265 1.2× 243 1.3× 25 0.2× 44 1.1k
Robert A. LeBœuf United States 22 500 1.1× 568 1.4× 312 1.4× 120 0.7× 36 0.2× 43 1.2k

Countries citing papers authored by Stephan Kirchner

Since Specialization
Citations

This map shows the geographic impact of Stephan Kirchner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Kirchner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Kirchner more than expected).

Fields of papers citing papers by Stephan Kirchner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Kirchner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Kirchner. The network helps show where Stephan Kirchner may publish in the future.

Co-authorship network of co-authors of Stephan Kirchner

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Kirchner. A scholar is included among the top collaborators of Stephan Kirchner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Kirchner. Stephan Kirchner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kirchner, Stephan, et al.. (2021). Cardiac Safety of Kinase Inhibitors – Improving Understanding and Prediction of Liabilities in Drug Discovery Using Human Stem Cell-Derived Models. Frontiers in Cardiovascular Medicine. 8. 639824–639824. 5 indexed citations
2.
Hebeisen, Paul, Wolfgang Haap, Bernd Kuhn, et al.. (2011). Orally active aminopyridines as inhibitors of tetrameric fructose-1,6-bisphosphatase. Bioorganic & Medicinal Chemistry Letters. 21(11). 3237–3242. 14 indexed citations
4.
Olaharski, Andrew, Nina Gonzaludo, David Goldstein, et al.. (2009). Identification of a Kinase Profile that Predicts Chromosome Damage Induced by Small Molecule Kinase Inhibitors. PLoS Computational Biology. 5(7). e1000446–e1000446. 41 indexed citations
5.
Olaharski, Andrew, Silvio Albertini, Stephan Kirchner, et al.. (2008). Evaluation of the GreenScreen GADD45α-GFP indicator assay with non-proprietary and proprietary compounds. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 672(1). 10–16. 14 indexed citations
6.
Muster, Wolfgang, Alexander Breidenbach, Holger Fischer, et al.. (2008). Computational toxicology in drug development. Drug Discovery Today. 13(7-8). 303–310. 142 indexed citations
7.
Olaharski, Andrew, Kyle L. Kolaja, Silvio Albertini, et al.. (2008). Response to “Genotoxic carcinogen or not genotoxic carcinogen? That is the question. Additional analysis of data from Olaharski et al.”. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 672(1). 20–20. 3 indexed citations
8.
Kirsch‐Volders, Micheline, Toshio Sofuni, Marilyn J. Aardema, et al.. (2003). Report from the in vitro micronucleus assay working group. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 540(2). 153–163. 510 indexed citations breakdown →
9.
Hude, Wilhelm von der, S. Kalweit, Günter Engelhardt, et al.. (2000). In vitro micronucleus assay with Chinese hamster V79 cells — results of a collaborative study with in situ exposure to 26 chemical substances. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 468(2). 137–163. 74 indexed citations
10.
Gocke, Elmar, et al.. (1998). The photomutagenicity of fluoroquinolones and other drugs. Toxicology Letters. 102-103. 375–381. 33 indexed citations
11.
Albertini, Silvio, Michael Bös, Elmar Gocke, et al.. (1998). Suppression of mutagenic activity of a series of 5HT2C receptor agonists by the incorporation of a gem-dimethyl group: SAR using the Ames test and a DNA unwinding assay. Mutagenesis. 13(4). 397–403. 10 indexed citations
12.
Kirchner, Stephan, et al.. (1997). [Clinical significance of tumor suppressor gene p53 in head and neck tumors].. PubMed. 45(9). 659–62. 1 indexed citations
13.
Jafari, Mehrdad, Thilo Papp, Stephan Kirchner, et al.. (1995). Analysis ofras mutations in human melanocytic lesions: activation of theras gene seems to be associated with the nodular type of human malignant melanoma. Journal of Cancer Research and Clinical Oncology. 121(1). 23–30. 69 indexed citations
14.
Papp, Thilo, et al.. (1995). Cloning of PCR fragments with a modified M13mp18 T-vector. Trends in Genetics. 11(5). 169–169. 5 indexed citations
15.
Kirchner, Stephan, Dietmar Schiffmann, & Helga Stopper. (1995). The influence of DNA methylation on topoisomerase II activity and its possible link with genomic instability in different cell lines of the syrian hamster. Toxicology in Vitro. 9(4). 519–525. 7 indexed citations
16.
Stopper, Helga, Stephan Kirchner, Dietmar Schiffmann, & Martin Poot. (1994). Cell Cycle Disturbance in Relation to Micronucleus Formation Induced by the Carcinogenic Estrogen Diethylstilbestrol. Pathobiology. 62(4). 180–185. 4 indexed citations
17.
Stopper, Helga, et al.. (1993). An investigation of micronucleus and mutation induction by oxazepam in mammalian cells. Mutagenesis. 8(5). 449–455. 19 indexed citations
18.
Kirchner, Stephan, Helga Stopper, Thilo Papp, et al.. (1993). Cytogenetic changes in primary, immortalized and malignant mammalian cells. Toxicology Letters. 67(1-3). 283–295. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026